Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
US Department of Justice
Federal Trade Commission
Chubb
Cipla
Johnson and Johnson
McKesson
Argus Health

Generated: April 24, 2018

DrugPatentWatch Database Preview

FLUMAZENIL Drug Profile

« Back to Dashboard

When do Flumazenil patents expire, and when can generic versions of Flumazenil launch?

Flumazenil is a drug marketed by Baxter Hlthcare Corp, Fresenius Kabi Usa, Hikma Farmaceutica, Mylan Labs Ltd, Sagent Pharms, Sandoz Inc, Teva Pharms Usa, and West-ward Pharms Int. and is included in nine NDAs.

The generic ingredient in FLUMAZENIL is flumazenil. There are four drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the flumazenil profile page.
Drug patent expirations by year for FLUMAZENIL
Pharmacology for FLUMAZENIL
Medical Subject Heading (MeSH) Categories for FLUMAZENIL
Synonyms for FLUMAZENIL
[11C]flumazenil
[11C]flumazenil (PET ligand)
[3H]Ro15-1788
40P7XK9392
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8- fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
755F814
78755-81-4
8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, ethyl ester
A839484
AB0014201
AB00572626_14
AB00572626_15
AB00572626-12
AB00572626-13
AB2000052
AC-6846
AC1L1FSE
AC1Q33UE
AFC-3002
AJ-08034
AK140079
AKOS015888159
AN-6313
Anexate
AOB5595
AS-13923
BDBM26263
BIDD:GT0766
Biomol-NT_000285
BPBio1_001190
BRD-K98769987-001-01-3
BRN 4763661
C07825
C15H14FN3O3
CAS-78755-81-4
CCG-100968
CHEBI:5103
CHEMBL407
CPD000058450
CS-0629
CTK8F9785
D00697
D02MTS
D0D5GD
DB01205
DR001229
DSSTox_CID_3064
DSSTox_GSID_23064
DSSTox_RID_76860
DTXSID2023064
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate
ETHYL 12-FLUORO-8-METHYL-9-OXO-2,4,8-TRIAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),3,5,11,13-PENTAENE-5-CARBOXYLATE
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0(2),]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate
ethyl 8-fluoranyl-5-methyl-6-oxidanylidene-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate #
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate
ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-3-carboxylate
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
EU-0100506
F 6300
F0958
Flumazenil (JAN/USP/INN)
Flumazenil (Ro 15-1788)
Flumazenil (transdermal patch formulation)
Flumazenil (transdermal patch formulation), Coeruleus
Flumazenil [USAN:BAN:INN]
Flumazenil [USAN:USP:INN:BAN]
Flumazenil authentic
Flumazenil, >99% (HPLC), solid
Flumazenil, United States Pharmacopeia (USP) Reference Standard
Flumazenilo
Flumazenilo [Spanish]
Flumazenilum
Flumazenilum [Latin]
Flumazepil
Flumazepil;Ro 15-1788;Anexate;Lanexat;Mazicon;Roma
Flumazil
Flumenazil
FlumUP TD
FT-0630863
fumazenil
GTPL4192
GTPL4367
HMS2051D17
HMS2089B15
HMS2234F06
HMS3261F13
HMS3267P09
HMS3374E10
HMS3393D17
HMS3657K11
HY-B0009
I01-0379
IMI061
K393
KS-00000XSM
Lanexat
Lopac-F-6300
Lopac0_000506
LP00506
LS-77778
Mazicon
MCULE-2830706565
MFCD00242764
MLS000028850
MLS000759529
MLS001076354
MLS001424108
MolPort-003-666-855
NC00218
NCGC00015439-01
NCGC00015439-02
NCGC00015439-03
NCGC00015439-04
NCGC00015439-05
NCGC00015439-06
NCGC00015439-07
NCGC00015439-08
NCGC00015439-09
NCGC00015439-11
NCGC00025116-01
NCGC00025116-02
NCGC00025116-03
NCGC00025116-04
NCGC00025116-05
NCGC00261191-01
NSC-759193
NSC759193
OFBIFZUFASYYRE-UHFFFAOYSA-N
Opera_ID_1516
PDSP1_001778
PDSP2_001761
Pharmakon1600-01505701
PL069864
Q-201122
Ro 15-1788
Ro 15-1788/000
Ro 151788
Ro-15-1788
Ro-15-1788/000
RO-151788
Ro-151788000
Ro15-1788
Roma
Romazicon
Romazicon (TN)
s1332
SAM001246763
SBB063113
SBI-0050490.P002
SC-15263
SCHEMBL79030
SMR000058450
ST24047162
TL8005362
Tocris-1328
Tox21_110148
Tox21_110148_1
Tox21_500506
UNII-40P7XK9392
UPCMLD-DP137
UPCMLD-DP137:001
W-5096
Z1551429735
ZB000344
ZINC1464

US Patents and Regulatory Information for FLUMAZENIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp FLUMAZENIL flumazenil INJECTABLE;INJECTION 076755-002 Oct 12, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int FLUMAZENIL flumazenil INJECTABLE;INJECTION 076787-001 Oct 12, 2004 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd FLUMAZENIL flumazenil INJECTABLE;INJECTION 078595-001 May 13, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa FLUMAZENIL flumazenil INJECTABLE;INJECTION 076955-001 Oct 12, 2004 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
Medtronic
Boehringer Ingelheim
Covington
Fuji
McKinsey
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.